dihydropyridines (BTG)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedihydropyridines (BTG)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsVoltage-gated calcium channel agonists
TargetsVoltage-gated calcium channelAdrenergic receptors alpha-1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBTG USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBTG USA Inc
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A